Drug Shortage Report for DUREZOL
Report ID | 46280 |
Drug Identification Number | 02415534 |
Brand name | DUREZOL |
Common or Proper name | DUREZOL .05% EMUL 5ML TRD |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | Difluprednate |
Strength(s) | 0.05% |
Dosage form(s) | EMULSION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-04-18 |
Actual start date | 2018-04-18 |
Estimated end date | 2018-05-04 |
Actual end date | 2018-04-19 |
Shortage status | Resolved |
Updated date | 2018-04-20 |
Company comments | Delay in testing |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-04-20 | English | Compare |
v6 | 2018-04-19 | French | Compare |
v5 | 2018-04-19 | English | Compare |
v4 | 2018-04-19 | English | Compare |
v3 | 2018-04-18 | French | Compare |
v2 | 2018-04-18 | English | Compare |
v1 | 2018-04-18 | English | Compare |
Showing 1 to 7 of 7